|
Group Post |
China is not reporting true impact of Covid outbreak, WHO says |
mike kraft |
|
Group Post |
CureVac says COVID vaccine produced immune response in early-stage trial |
mike kraft |
|
Group Post |
People who haven't had COVID will likely catch the new XBB.1.5 variant, experts say |
mike kraft |
|
Group Post |
CDC revises figures, says Omicron subvariant XBB.1.5 accounts for 27.6% of U.S. COVID cases |
mike kraft |
|
Group Post |
China’s Covid wave threatens delays in U.S. and other medical supply chains |
mike kraft |
|
Group Post |
New studies outline Omicron immune protection after infection, vaccination |
mike kraft |
|
Group Post |
Omicron COVID booster cuts hospitalization in over 65s -- Israeli study |
mike kraft |
|
Group Post |
Analysis: New variant XBB.1.5 is ‘most transmissible’ yet, could fuel covid wave |
mike kraft |
|
Group Post |
Chinese rush to renew passports as COVID border curbs lifted |
mike kraft |
|
Group Post |
China: More than 88 million people in Henan province infected with Covid, official says |
mike kraft |
|
Group Post |
Long COVID: Researcher Finds There Are 4 Subtypes |
mike kraft |
|
Group Post |
WHO backs mask wearing on long flights; Advice on avoiding infectionns whle flying |
mike kraft |
|
Group Post |
Here's What Experts Expect The COVID-19 Pandemic To Be Like This Year |
mike kraft |
|
Group Post |
More US schools require mask as COVID cases rise |
mike kraft |
|
Group Post |
Moderna reported to charge $130 for Covid vaccine dose, Senator Sanders calls the charges outrageous |
mike kraft |
|
Group Post |
Global COVID vaccine acceptance rose 5% from 2021 to 2022 --survey |
mike kraft |
|
Group Post |
Cold-like' symptoms could indicate the XBB.1.5 Covid variant |
mike kraft |
|
Group Post |
Countries ponder wider wastewater testing in hopes it willl offer China COVID-19 clues |
mike kraft |
|
Group Post |
Uganda declares itself Ebola-free after containing latest outbreak |
mike kraft |
|
Group Post |
Merck's COVID treatment expected to launch in China on Friday |
mike kraft |
|
Group Post |
U.S. FDA vaccine advisers reported upset that early data about new Moderna Covid-19 booster shot wasn’t presented for review last year |
mike kraft |
|
Group Post |
U.S. extends public health emergency status for COVID |
mike kraft |
|
Group Post |
Wastewater data should become a more mainstream public health tool |
mike kraft |
|
Group Post |
Bivalent COVID vaccines: how they're stacking up against omicron |
mike kraft |
|
Group Post |
Mpox has faded in the US. Who deserves the credit? |
mike kraft |
Recent Comments